Business Context and Reporting Period
Company: Odyssey Marine Exploration, Inc. (OMEX)
Filing Type: Form 8-K (Current Report)
Report Date: July 28, 2025 (Events reported July 28, 29, and 31, 2025)
Reporting Period: Specific transaction dates in late July 2025.
Key Financial Metrics and Capital Structure
- Cash Raised: $4,419,836 from the exercise of purchase rights under the December 2024 Purchase Agreement.
- Debt Reduction: $1,000,000 of indebtedness under the March 2023 Notes was converted into equity.
- Shares Issued:
- 909,090 shares issued via debt conversion.
- 4,018,033 shares issued via cash purchase.
- Total Outstanding Shares: 39,134,525 shares of common stock following these issuances.
- Remaining Debt Obligation: The filing references the March 2023 Notes (original principal $14.0 million) but does not state the remaining balance after the $1.0 million conversion.
- Remaining Purchase Rights: Investors retain the right to purchase an additional 7,220,141 shares at $1.10 per share under the December 2024 agreement.
Note: The filing does not provide data on revenue, operating profit, cash flow from operations, or margins.
Material Changes Versus Prior Period
This filing reports discrete capital events rather than a comparative period analysis. The material changes include:
- Reduction of outstanding debt by $1,000,000 through conversion.
- Increase in share count by approximately 4.9 million shares (909,090 + 4,018,033).
- Inflow of approximately $4.42 million in cash proceeds.
Guidance, Outlook, and Risks
Management Commentary: The filing contains no forward-looking guidance, outlook, or management discussion regarding future operations or financial performance.
Risks and Contingencies:
- Dilution: The issuance of new shares increases the total share count, potentially diluting existing shareholders.
- Future Capital Calls: Investors hold the right to purchase an additional 7,220,141 shares at $1.10 per share, which could result in further dilution if exercised.
- Regulatory Exemption: The transactions were conducted under Section 4(a)(2) and Rule 506 exemptions, indicating reliance on private placement rules.
Key Facts for Investor Verification
- Verify the remaining principal balance of the March 2023 Notes after the $1.0 million conversion.
- Confirm the total cash on hand and liquidity position following the $4.42 million infusion.
- Assess the impact of the increased share count (39,134,525 total) on earnings per share (EPS) and book value.
- Monitor the status of the remaining 7,220,141 shares available for purchase under the December 2024 agreement.